Description

Sermorelin is a synthetic peptide modeled after a fragment of growth hormone–releasing hormone (GHRH), a naturally occurring signaling molecule involved in growth hormone regulation. In laboratory and pre-clinical research, sermorelin has been studied for its interaction with pituitary signaling pathways and its role in stimulating endogenous growth hormone release at the cellular level.

Researchers use sermorelin to explore how GHRH-based peptides influence hormone signaling, circadian secretion patterns, and downstream metabolic pathways. Its selective receptor activity makes it a compound of interest in studies related to endocrine communication, growth hormone dynamics, and cellular regulation.

For research use only.

This compound is not approved for human or veterinary use and is intended exclusively for in-vitro and laboratory research conducted by qualified professionals.